MetaCap

Capstone (CAPS) vs Processa Pharmaceuticals (PCSA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Processa Pharmaceuticals is the larger company by market cap ($3.8 million vs $3.7 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

CAPS versus PCSA key metrics
MetricCAPSPCSA
Share price$0.1409$1.35
Market cap$3.72M$3.77M
1-day change+0.57%-4.93%
EPS (TTM)$-3.27$-4.33
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$1.36$11.08
52-week low$0.13$1.32
Distance from 52-week high-89.64%-87.81%
Analyst consensusnone—
Avg. price target upside+2029.17%—
Average volume4.35M224.03K
Shares outstanding26.38M2.79M
Employees9312
SectorBasic MaterialsHealthcare
IndustryBuilding MaterialsBiotechnology

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • The two companies sit in different sectors: Capstone in Basic Materials and Processa Pharmaceuticals in Healthcare.

About Capstone

CAPS stock →

Capstone Holding Corp., through its subsidiaries, engages in the distribution and installation of building products in the United States and Canada. It operates in two segments, TotalStone and Carolina Stone.

Basic Materials · Building Materials · 93 employees

About Processa Pharmaceuticals

PCSA stock →

Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States. The company's drugs are modifications of existing FDA-approved oncology drugs, resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms for killing cancer cells.

Healthcare · Biotechnology · 12 employees

CAPS vs PCSA FAQ

Which is bigger, Capstone or Processa Pharmaceuticals?

Processa Pharmaceuticals (PCSA) is larger, with a market capitalization of $3.77M compared with $3.72M for Capstone (CAPS).

Are Capstone and Processa Pharmaceuticals in the same industry?

No. Capstone is in the Basic Materials sector, while Processa Pharmaceuticals is in Healthcare.

More comparisons